Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong · Delayed Price · Currency is HKD 1.040
+0.040 (4.00%)
Jul 31, 2026, 3:53 PM HKT
HKG:2348 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,231 | 1,231 | 1,060 | 1,151 | 1,278 | 1,165 |
Revenue Growth | 10.56% | 16.09% | -7.89% | -9.90% | 9.66% | 13.76% |
Gross Profit Gross Profit Growth | 557.4 | 557.4 | 532.06 | 628.48 | 766.68 | 675.36 |
Operating Income Operating Income Growth | 227.42 | 227.42 | 202.05 | 275.99 | 419.1 | 380.76 |
Net Income Net Income Growth | 213.97 | 213.97 | 564.94 | 326 | 358.06 | 358.18 |
Earnings Per Share EPS Growth | 0.14 | 0.14 | 0.38 | 0.22 | 0.24 | 0.24 |
EPS Growth | 19.46% | -62.71% | 73.00% | -8.94% | 0.34% | 36.89% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Finished Drugs Finished Drugs Growth | 1,161 | 1,161 | 1,018 | 1,022 | 1,137 | 1,011 |
Elimination of Intersegment Sales Elimination of Intersegment Sales Growth | -107.06 | -107.06 | -109.32 | -80.63 | -64.64 | -61.42 |
Intermediates and Bulk Medicines Intermediates and Bulk Medicines Growth | 177.27 | 177.27 | 151.36 | 210.05 | 205.09 | 215.56 |
Total Total Growth | 1,231 | 1,231 | 1,060 | 1,151 | 1,278 | 1,165 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,805 | 1,805 | 1,608 | 1,174 | 1,082 | 830.22 |
Total Debt Total Debt Growth | 77.48 | 77.48 | 34.72 | 120.53 | 8.41 | 23.52 |
Net Cash (Debt) Net Cash Growth | 1,727 | 1,727 | 1,573 | 1,053 | 1,073 | 806.7 |
Net Cash Growth | 7.14% | 9.81% | 49.36% | -1.89% | 33.06% | -15.90% |
Net Cash Per Share Net Cash Per Share Growth | 1.15 | 1.15 | 1.04 | 0.70 | 0.71 | 0.53 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 355.41 | 355.41 | 220.2 | 338.4 | 434.27 | 393.14 |
Capital Expenditures CapEx Growth | -86 | -86 | -126.04 | -199.55 | -204.37 | -313.07 |
Free Cash Flow Free Cash Flow Growth | 269.41 | 269.41 | 94.16 | 138.85 | 229.9 | 80.07 |
Free Cash Flow Growth | 37.52% | 186.13% | -32.19% | -39.61% | 187.12% | -51.12% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 45.28% | 45.28% | 50.18% | 54.60% | 60.00% | 57.96% |
Operating Margin | 18.48% | 18.48% | 19.06% | 23.97% | 32.80% | 32.68% |
Pretax Margin | 20.28% | 20.28% | 60.07% | 35.97% | 34.31% | 37.71% |
Profit Margin | 17.38% | 17.38% | 53.28% | 28.32% | 28.02% | 30.74% |
FCF Margin | 21.89% | 21.89% | 8.88% | 12.06% | 17.99% | 6.87% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.063 | 0.057 | 0.059 | 0.073 | 0.078 | 0.065 |
Dividend Per Share Growth | -33.68% | -4.37% | -18.48% | -6.71% | 19.44% | 19.08% |
Dividend Yield | 6.06% | 5.40% | 5.86% | 9.25% | 8.62% | 6.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.68 | 7.70 | 3.05 | 4.39 | 4.93 | 5.69 |
Forward PE | - | 8.59 | 8.59 | 8.59 | 8.59 | 8.59 |
P/FCF Ratio | 5.22 | 6.12 | 18.29 | 10.30 | 7.67 | 25.46 |
PS Ratio | 1.14 | 1.34 | 1.62 | 1.24 | 1.38 | 1.75 |